Amgen has launched its new commercial office in Hong Kong. Amgen’s entry into the region aims to foster more research collaborations and bring innovative therapies to local patients. The company’s Japan Asia Pacific (JAPAC) regional headquarters are also based at its One Island East offices, Taikoo Place, Hong Kong.

“In 2007, Amgen opened a clinical development hub in Hong Kong with fewer than ten people. Today, we are delighted to launch our Hong Kong/Macau commercial office. We expect to employ more than 80 people by the end of the year in Hong Kong, serving patients locally and in the rest of the JAPAC region,” said Penny Wan, regional vice president and general manager of Amgen’s JAPAC region.

The company has recently appointed Eric Ng as general manager of the Amgen South East Asia, Hong Kong and India region, and KK Tong as country director of the Amgen Hong Kong. Both bring more than 20 years of experience in the healthcare and pharmaceutical industry across broad geographies and business areas.

“We’re very pleased to have established this commercial office in Hong Kong and we look forward to growing our team here,” said KK Tong. “As a biotechnology pioneer, we hope to help the advancement and growth of the biotechnology community in Hong Kong and Macau.”